| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0056 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |